Geary Richard S, EVP and Chief Development Officer at IONIS Pharmaceuticals Inc. ($IONS), sold about $14.3 million in company shares through 14 open market transactions over the past year. His most recent sale occurred on November 6, 2025. These sales rank him 872nd among 11,678 insiders by total value sold, above the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 775 | $60.89 | 60,432.0000 | 158,964,772 | 1.30% | 0.00% |
| Nov. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 14738 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.01% |
| Nov. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 800 | $0.00 | 14,738.0000 | 158,964,772 | 5.15% | 0.00% |
| Nov. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 18300 | $60.89 | 77,957.0000 | 158,964,772 | 30.68% | 0.01% |
| Nov. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 14738 | $76.10 | 59,657.0000 | 158,964,772 | 19.81% | 0.01% |
| Nov. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 14738 | $56.78 | 74,395.0000 | 158,964,772 | 24.70% | 0.01% |
| Nov. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 801 | $75.01 | 59,657.0000 | 158,964,772 | 1.32% | 0.00% |
| Nov. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 801 | $60.89 | 60,458.0000 | 158,964,772 | 1.34% | 0.00% |
| Nov. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 800 | $56.78 | 60,457.0000 | 158,964,772 | 1.34% | 0.00% |
| Nov. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 800 | $75.01 | 59,657.0000 | 158,964,772 | 1.32% | 0.00% |
| Nov. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 18300 | $75.42 | 59,657.0000 | 158,964,772 | 23.47% | 0.01% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 775 | $75.05 | 59,657.0000 | 158,964,772 | 1.28% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 905 | $56.78 | 60,562.0000 | 158,964,772 | 1.52% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 905 | $75.05 | 59,657.0000 | 158,964,772 | 1.49% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 905 | $0.00 | 15,538.0000 | 158,964,772 | 5.50% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 775 | $0.00 | 19,101.0000 | 158,964,772 | 3.90% | 0.00% |
| Nov. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 18300 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.01% |
| Nov. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 801 | $0.00 | 18,300.0000 | 158,964,772 | 4.19% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 775 | $56.78 | 60,432.0000 | 158,964,772 | 1.30% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 905 | $0.00 | 18,971.0000 | 158,964,772 | 4.55% | 0.00% |
| Oct. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 34585 | $0.00 | 19,876.0000 | 158,964,772 | 63.50% | 0.02% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 775 | $0.00 | 15,668.0000 | 158,964,772 | 4.71% | 0.00% |
| Oct. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 34664 | $0.00 | 16,443.0000 | 158,964,772 | 67.83% | 0.02% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 905 | $75.05 | 59,657.0000 | 158,964,772 | 1.49% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 905 | $60.89 | 60,562.0000 | 158,964,772 | 1.52% | 0.00% |
| Nov. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 775 | $75.05 | 59,657.0000 | 158,964,772 | 1.28% | 0.00% |
| Oct. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 20000 | $75.11 | 59,657.0000 | 158,964,772 | 25.11% | 0.01% |
| Oct. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 34664 | $75.11 | 79,657.0000 | 158,964,772 | 30.32% | 0.02% |
| Oct. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 34664 | $56.78 | 114,321.0000 | 158,964,772 | 43.52% | 0.02% |
| Oct. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 34585 | $75.11 | 79,657.0000 | 158,964,772 | 30.27% | 0.02% |
| Oct. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 34585 | $60.89 | 114,242.0000 | 158,964,772 | 43.42% | 0.02% |
| Sept. 30, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 57900 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.04% |
| Sept. 30, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 57900 | $53.77 | 137,557.0000 | 158,964,772 | 72.69% | 0.04% |
| Sept. 30, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 57900 | $65.24 | 79,657.0000 | 158,964,772 | 42.09% | 0.04% |
| Sept. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 10000 | $50.37 | 79,657.0000 | 158,964,772 | 11.15% | 0.01% |
| Aug. 29, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | J | Common Stock | 165 | $27.71 | 89,657.0000 | 158,964,772 | 0.18% | 0.00% |
| Aug. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 10000 | $42.86 | 89,492.0000 | 158,964,772 | 10.05% | 0.01% |
| Feb. 28, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | J | Common Stock | 415 | $28.21 | 99,492.0000 | 158,964,772 | 0.42% | 0.00% |
| Jan. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 1406 | $32.40 | 99,077.0000 | 0 | 1.40% | 0.00% |
| Jan. 30, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Common Stock | 3820 | $0.00 | 100,483.0000 | 0 | 3.95% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Restricted Stock Unit | 18901 | $0.00 | 60,724.0000 | 0 | 23.74% | 0.00% |
| Jan. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 7072 | $32.86 | 96,663.0000 | 0 | 6.82% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Performance Restricted Stock Units | 22000 | $0.00 | 64,801.0000 | 0 | 51.40% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Restricted Stock Unit | 33000 | $0.00 | 79,625.0000 | 0 | 70.78% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 18901 | $0.00 | 103,735.0000 | 0 | 22.28% | 0.00% |
| Jan. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Non-Qualified Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 30, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | J | Common Stock | 11 | $38.64 | 84,834.0000 | 0 | 0.01% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 1995 | $50.04 | 87,300.0000 | 0 | 2.23% | 0.00% |
| Aug. 28, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 320 | $49.16 | 85,154.0000 | 0 | 0.37% | 0.00% |
| Aug. 29, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 331 | $49.63 | 84,823.0000 | 0 | 0.39% | 0.00% |
| Aug. 5, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 2430 | $48.00 | 85,508.0000 | 0 | 2.76% | 0.00% |
| Feb. 29, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | Officer Level 14 | J | Common Stock | 604 | $34.43 | 87,938.0000 | 0 | 0.69% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 1961 | $50.04 | 87,334.0000 | 0 | 2.20% | 0.00% |
| Feb. 1, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Common Stock | 3820 | $0.00 | 89,295.0000 | 0 | 4.47% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 19852 | $0.00 | 92,813.0000 | 0 | 27.21% | 0.00% |
| Jan. 17, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 7338 | $50.42 | 85,475.0000 | 0 | 7.91% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Restricted Stock Unit | 19852 | $0.00 | 46,625.0000 | 0 | 29.86% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Restricted Stock Unit | 20400 | $0.00 | 66,477.0000 | 0 | 44.27% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Performance Restricted Stock Units | 17000 | $0.00 | 42,801.0000 | 0 | 65.89% | 0.00% |
| Jan. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Non-Qualified Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| Dec. 20, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 6500 | $49.64 | 72,961.0000 | 0 | 8.18% | 0.00% |
| Dec. 20, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 6500 | $47.34 | 79,461.0000 | 0 | 8.91% | 0.00% |
| Dec. 21, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 4112 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 20, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 6500 | $0.00 | 4,112.0000 | 0 | 61.25% | 0.00% |
| Dec. 21, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 4112 | $49.29 | 72,961.0000 | 0 | 5.34% | 0.00% |
| Dec. 21, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 4112 | $47.34 | 77,073.0000 | 0 | 5.64% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 4042 | $50.19 | 72,961.0000 | 0 | 5.25% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 4042 | $0.00 | 10,612.0000 | 0 | 27.58% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 4042 | $47.34 | 77,003.0000 | 0 | 5.54% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 6571 | $49.21 | 72,961.0000 | 0 | 8.26% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 6571 | $47.34 | 79,532.0000 | 0 | 9.01% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Non-Qualified Stock Option (right to buy) | 6571 | $0.00 | 14,654.0000 | 0 | 30.96% | 0.00% |
| Aug. 31, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | Officer Level 14 | J | Common Stock | 1 | $30.56 | 72,961.0000 | 0 | 0.00% | 0.00% |
| Feb. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | J | Common Stock | 575 | $30.52 | 72,960.0000 | 0 | 0.79% | 0.00% |
| Feb. 6, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 1920 | $40.66 | 72,385.0000 | 0 | 2.58% | 0.00% |
| Feb. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Common Stock | 3822 | $0.00 | 74,305.0000 | 0 | 5.42% | 0.00% |
| Jan. 18, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | S | Common Stock | 7873 | $39.57 | 70,483.0000 | 0 | 10.05% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Restricted Stock Unit | 21983 | $0.00 | 46,077.0000 | 0 | 32.30% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | M | Common Stock | 21983 | $0.00 | 78,356.0000 | 0 | 39.00% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Restricted Stock Unit | 17207 | $0.00 | 68,060.0000 | 0 | 33.84% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Performance Restricted Stock Units | 14338 | $0.00 | 25,801.0000 | 0 | 125.08% | 0.00% |
| Jan. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Geary Richard S | EVP, Chief Development Officer | A | Non-Qualified Stock Option (right to buy) | 22942 | $0.00 | 22,942.0000 | 0 | 9999.99% | 0.00% |